Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Yoder

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Brachytherapy|August 23, 2021
PSA: Declining utilization of prostate brachytherapyLauren Andring, Alison Yoder, Todd Pezzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancerAdnan Elhammali, Pierre Blanchard, Alison Yoder, et al.
Gynecologic Oncology|January 3, 2022
Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysisKelsey L Corrigan, Alison Yoder, Brian De, et al.
Advances in Radiation Oncology|January 6, 2026
The Impact of Radiation Dose to Bowel on the Risk of Developing Gastrointestinal Toxicities When Treating Abdominopelvic Soft-Tissue Sarcomas With Preoperative Radiation TherapyAlison Yoder, Tucker Netherton, Xin Wang, et al.
Haematologica|January 11, 2020
New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicityAdnan Elhammali, Behrang Amini, Ethan B Ludmir, et al.
Practical Radiation Oncology|January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue SarcomaAndrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Journal of Medical Imaging (Bellingham, Wash.)|November 8, 2023
Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of <i>in vivo</i> site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer, Travis C Salzillo, M Alex Dresner, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 29, 2019
Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?Adnan Elhammali, Sarah A Milgrom, Behrang Amini, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Brachytherapy|August 23, 2021
PSA: Declining utilization of prostate brachytherapyLauren Andring, Alison Yoder, Todd Pezzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancerAdnan Elhammali, Pierre Blanchard, Alison Yoder, et al.
Gynecologic Oncology|January 3, 2022
Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysisKelsey L Corrigan, Alison Yoder, Brian De, et al.
Advances in Radiation Oncology|January 6, 2026
The Impact of Radiation Dose to Bowel on the Risk of Developing Gastrointestinal Toxicities When Treating Abdominopelvic Soft-Tissue Sarcomas With Preoperative Radiation TherapyAlison Yoder, Tucker Netherton, Xin Wang, et al.
Haematologica|January 11, 2020
New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicityAdnan Elhammali, Behrang Amini, Ethan B Ludmir, et al.
Practical Radiation Oncology|January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue SarcomaAndrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Journal of Medical Imaging (Bellingham, Wash.)|November 8, 2023
Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of <i>in vivo</i> site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer, Travis C Salzillo, M Alex Dresner, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 29, 2019
Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?Adnan Elhammali, Sarah A Milgrom, Behrang Amini, et al.
Pageof 1